Amarin is making a final effort in the federal judiciary to compel the U.S. International Trade Commission to investigate its complaint over the legality of certain “synthetically produced omega-3 products” promoted as dietary supplements, a category of products principally regulated by FDA.
Amarin asks Supreme Court to hear dispute involving omega-3 supplements
Wednesday, July 31st, 2019